- Highlights the climate crisis facing the Himalayas and underscores the need for international solidarity and collective action- Held in Namche Bazaar, Nepal, the...
The Korean specialty ingredient company - Shinsung Materials - expands its portfolio across preservative systems, UV solutions, oil thickeners, and emulsifiersSEOUL, South Korea, June...
- Highlights the climate crisis facing the Himalayas and underscores the need for international solidarity and collective action- Held in Namche Bazaar, Nepal, the...
VESALIUS-CV Subgroup Results Show Repatha® Reduces Risk of First Major Cardiovascular Events by 29% in People Living with High-Risk DiabetesNew Real-World Data Highlight Treatment...
What's happening: Temperatures are forecast to reach the 90s, pushing cooling systems to run longer and use more energy to maintain indoor temperaturesWhy it...
GENEVA, June 05, 2026 (GLOBE NEWSWIRE) -- TRON DAO, the community-governed DAO dedicated to accelerating the decentralization of the internet through blockchain technology and decentralized applications (dApps), today announced the spot listing of TRX, the native utility token of the TRON network, on Bitnomial, a CFTC -regulated U.S. exchange and clearinghouse.
The listing expands access to TRX for U.S. market participants through a regulated trading venue, providing investors and institutions with an additional platform to access the native utility token of the TRON blockchain. TRX supports transactions, smart contract execution, decentralized applications, and network governance across one of the world's most active blockchain ecosystems. TRON is recognized as a leading blockchain for stablecoin activity and digital asset settlement, hosting more than $89 billion in circulating USDT and over $27 billion in total value locked (TVL).
“Bitnomial’s listing of TRX is an important step in expanding access to TRON through regulated U.S. market infrastructure,” said Justin Sun, Founder of TRON. “As demand for compliant digital asset products continues to grow, the availability of TRX on regulated platforms supports broader market access, greater transparency and the continued maturation of the digital asset ecosystem.”
Bitnomial, LLC, headquartered in Chicago, is a derivatives exchange company that owns and operates U.S. CFTC-regulated exchange (DCM), clearinghouse (DCO), and clearing brokerage (FCM) subsidiaries. Bitnomial offers leveraged spot, perpetuals, futures, options, and prediction markets on a single unified exchange and clearinghouse with digital asset margin and settlement capabilities.
The addition of TRX further expands the range of digital assets available on regulated U.S. financial infrastructure, building on a series of recent developments that have strengthened the institutional foundation of the TRON network. In recent months, TRX became available for custody through Anchorage Digital, the first federally chartered crypto bank in the United States, supporting the expansion of tokenized real-world asset products with top-tier asset managers on the network.
As digital asset markets continue to evolve, open blockchain networks remain central to expanding access to transparent, permissionless financial infrastructure. The Bitnomial listing reflects continued progress toward making blockchain-based assets more accessible through reliable and established market infrastructure.
Historic Nancy Island, World Cup watch parties and a beachfront symphony fireworks show bring Canadian history, culture and celebration together on the shores of Georgian...
The multi-day event united global creators in Hollywood for a content creation competition experience to educate and entertain consumers on healthy skin habits.NEW YORK,...
The multi-day event united global creators in Hollywood for a content creation competition experience to educate and entertain consumers on healthy skin habits.NEW YORK,...
SHANGHAI, June 5, 2026 /PRNewswire/ -- LongBio Pharma, a portfolio company of Qiming Venture Partners and a leading innovative drug developer for allergic and...
SHANGHAI, June 5, 2026 /PRNewswire/ -- LongBio Pharma, a portfolio company of Qiming Venture Partners and a leading innovative drug developer for allergic and...